期刊文献+

帕金森病伴发抑郁患者血浆谷氨酸和γ-氨基丁酸水平的改变及其临床意义 被引量:12

The plasma levels of glutamate and γ-aminobutyric acid in Parkinson's disease patients with depression and their clinical significance
下载PDF
导出
摘要 目的探讨帕金森病伴发抑郁(Parkinson disease with depression,PDD)患者血浆谷氨酸(glutamate,Glu)和γ-氨基丁酸(γ-aminobutyric acid,GABA)水平的改变及其临床意义。方法采用高效液相色谱-荧光检测法(high performance liquid chromatography,HPLC-RF)检测88例PD患者,其中43例PDD患者,45例非PDD患者,以及68例健康对照者(对照组)血浆Glu、GABA水平,运用汉密尔顿抑郁量表(Hamilton Depression Scale,HAMD)对所有研究对象进行评估。比较各组血浆Glu、GABA水平的差异,并对血浆氨基酸神经递质水平与HAMD评分进行相关性分析。结果 PD患者血浆Glu、GABA水平(49.81±22.79,249.17±62.57)较正常对照组(149.59±50.08,276.66±85.43)均显著降低(均P<0.05),并且PDD组血浆Glu、GABA水平(40.34±15.77,233.63±53.56)分别显著低于非PDD组(58.86±24.87,264.02±67.39)及对照组(均P<0.05)。相关性分析提示HAMD评分与血浆Glu水平(r=-0.366,P=0.000)及血浆GABA水平(r=-0.217,P=0.043)呈显著负相关。结论 PD患者血浆Glu、GABA水平的下降可能与PDD的发病有关。 ObjectiveTo investigate the plasma levels of glutamate(Glu) and γ-aminobutyric acid(GABA) in Parkinson’s disease patients with depression(PDD) and their clinical significance.MethodsPlasma levels of Glu and GABA were measured in 88 PD patients including 43 PDD patients and 45 PD patients without depression, and 68 healthy controls by using high performance liquid chromatography(HPLC-RF). Depression was assessed in enrolled subjects by using the Hamilton Depression Scale(HAMD). The plasma levels of Glu and GABA were compared among different groups and their associations with HAMD scores were subsequently evaluated by correlation analysis.ResultsThe plasma levels of Glu and GABA were significantly lower in PD group(49.81±22.79,249.17±62.57)than in normal control group(149.59±50.08,276.66±85.43)(all P〈0.05). In addition, PD patients with depression exhibited significantly lower plasma levels of Glu and GABA(40.34±15.77 and 233.63±53.56)compared to PD patients without depression(58.86±24.87 and 264.02±67.39)and healthy controls(all P〈0.05). Correlation analysis indicated that HAMD scores were negatively associated with plasma levels of Glu( r =-0.366,P= 0.000) and GABA( r=-0.217,P = 0.043).Conclusion The decrease in plasma levels of Glu and GABA may be implicated in the pathogenesis of depression in PD patients.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2015年第4期224-228,共5页 Chinese Journal of Nervous and Mental Diseases
基金 江苏省高校自然科学研究项目(编号:13KJB32009) 江苏省自然科学基金(编号:BK20141494) 江苏省神经退行性疾病重点实验室开放课题(编号:SJ11KF01) 江苏高校优势学科建设工程资助项目(PAPD)(210029)
关键词 帕金森病 谷氨酸 Γ-氨基丁酸 抑郁 Parkinson’s disease glutamate γ-aminobutyric acid depression
  • 相关文献

参考文献19

  • 1Santos-Garcia D de la Fuente-Fernandez R. Impact of non-mo- tor symptoms on heahh-related and perceived quality of life in Parkinson's disease[J1. J Neurol Sci, 2013, 332(1-2): 136-140.
  • 2刘万根.帕金森病患的非运动症状及对健康相关生活质量的影响.河北医科大学,2012.
  • 3Griffith HR, Okonkwo OC, O'Brien T, et al. Reduced brain glu- tamate in patients with Parkinson's disease[,l]. NMR Biomed, 2008, 21(4): 381-387.
  • 4Tohgi H, Abe T, Hashiguehi K, et al. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of pa- tients with Parkinson's disease and spinocerebellar degeneration [J]. Neurosci I,ett, 1991, 126(2): 155-158.
  • 5Sanacora G, Treccani G, Popoli M. Towards a glutamate hypoth- esis of depression: an emerging frontier of neuropsychophamla-cology Ibr mood disorders[J]. Neuropharmaology, 2012, 62(1): 63-77.
  • 6Brambilla P, Perez J, Barale F, et al. GABAergic" dysfunction in mood disorders[J]. Mol Psychiatry, 2003, 8(8): 721-737, 715.
  • 7张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:617
  • 8袁永胜,佟晴,徐勤荣,葛颂,孙红彬,单瀚,张克忠.早期帕金森病患者血浆谷氨酸、天冬氨酸和γ-氨基丁酸水平的改变及其诊断价值的研究[J].中国临床神经科学,2013,21(6):601-605. 被引量:10
  • 9Wenzelburger R, Zhang BR, Pohle S, et al. Force overflow and levodopa-induced dyskinesias in Parkinson's disease[J]. Brain, 2002, 125(Pt 4): 871-879.
  • 10Inoue T, Kitagawa M, Tanaka T, et al. Depression and major de- pressive disorder in patients with Parkinson's disease[J]. Mov Disord, 2010, 25(1): 44-49.

二级参考文献49

  • 1Calne DB,Snow BJ,Lee C.Criteria for diagnosing Parkinson's disease.Ann Neurol,1992,32 Suppl:125-127.
  • 2Gelb GJ,Oliver E,Gilman S.Diagnostic criteria for Parkinson's disease.Arch Neurol,1999,56:33-39.
  • 3Gibb WRG.The neuropathology of Parkinson's disease.In:Jankovic J,Tolosa E,eds.Parkinson's disease and movement disorders.Baltimore:Urban and Schwarzenberg,1988.205-223.
  • 4Koller WC.How accurately can Parkinson's disease be diagnosed?Neurology,1992,42Suppl 1:6-16.
  • 5Paulson HL,Stern M.Clinical Manifestations of Parkinson's disease.In:Watts RL,Koller WC,eds.Movement disorders.New York:McGraw-Hill,2004.233-245.
  • 6Hughes AJ,Daniel SE,Kilford L,et al.Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinico-pathological study of 100 cases.J Neurol Neurosurg Psychiatry,1992,55:181-184.
  • 7The Guideline Review Panel of NICE (the national institute for clinical excellence).Diagnosis and management in primary and secondary care.In Parkinson's disease--full guideline,second consultation,2006.34-38.
  • 8Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease[Jl. Mov Disord,2008,23(2) : 185-189;313.
  • 9Lieberman A. Depression in Parkinson's disease-a review [J]. Acta Neurol Scand, 2006,113 ( 1 ) : 1-8.
  • 10Negre-Pages L, Grandjean H, Lapeyre-Mestre M, et al. Anx- ious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study [J ]. Mov Disord, 2010, 25(2) : 157-166.

共引文献632

同被引文献116

引证文献12

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部